Here Is Why Viking Therapeutics (VKTX) is Amongst The Most Affordable Biotech Stocks to Buy

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the 10 affordable biotech stocks to buy right now.

On June 24, Viking Therapeutics Inc. (NASDAQ:VKTX) disclosed the launch of a Phase 1 Single Ascending Dose (SAD) medical study of VK3019. VK3019 is an experimental Dual Amylin and Calcitonin Receptor Agonist (DACRA), being developed as a possible weight loss therapy.

Pressmaster/Shutterstock.com

The study was initiated after the submission and clearance of the investigational new drug filing of VK3019 with the FDA. The Phase 1 study is a placebo-controlled, randomized, double-blind SAD study in healthy adults with a BMI equal to or greater than 30. The main objectives include assessing the tolerability, safety, and pharmacokinetics of one-time under-the-skin VK3019 doses.

Exploratory analyses include variations in body weight following a one-time dose administration. Besides the Phase 1 trial, Viking is presently performing the Phase 3 VANQUISH studies of under-the-skin VK2735 in overweight patients or patients with obesity.

The company is also working on VK2735’s oral tablet formulation and expects to launch a Phase 3 trial assessing oral VK2735 for overweight and obesity later this year. The company plans to report the findings of the study during the third quarter.

Viking Therapeutics Inc. (NASDAQ:VKTX) specializes in metabolic and endocrine disorder therapies. As a clinical-stage biopharmaceutical company, they direct their research efforts towards small-molecule drugs to cure obesity, fatty liver, and diabetes.

While we acknowledge the risk and potential of VKTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than VKTX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1